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Background: Atopic march refers to the typical transition from a food allergy in early childhood to allergic asthma
in older children and adults. However the precise interplay of events involving gut, skin and pulmonary
inflammation in this process is not completely understood.
Objectives: To develop a mouse model of mixed food and respiratory allergy mimicking the atopic march and
better understand the impact of food allergies on asthma.
Methods: Food allergy to ovalbumin (OVA) was induced through intra-peritoneal sensitization and intra-gastric
challenge, and/or a respiratory allergy to house dust mite (HDM) was obtained through percutaneous sensitization
and intra-nasal challenges with dermatophagoides farinae (Der f) extract. Digestive, respiratory and systemic
parameters were analyzed.
Results: OVA-mediated gut allergy was associated with an increase in jejunum permeability, and a worsening of
Der f-induced asthma with stronger airway hyperresponsiveness and pulmonary cell infiltration, notably eosinophils.
There was overproduction of the pro-eosinophil chemokine RANTES in broncho-alveolar lavages associated with an
enhanced Th2 cytokine secretion and increased total and Der f-specific IgE when the two allergies were present.
Both AHR and lung inflammation increased after a second pulmonary challenge.
Conclusion: Gut sensitization to OVA amplifies Der f-induced asthma in mice.
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Asthma, a common chronic respiratory disease, affects
nearly 300 million people worldwide, and its prevalence
exceeds 10% of the population in many industrialized
countries [1]. Airway obstruction in asthma and the re-
sulting symptoms are caused by a combination of airway
smooth muscle constriction and inflammation of the
bronchi [2]. Among the various phenotypes of asthma,
early-onset atopic Th2 [3] type is commonly associated
with allergic disorders and appears to be the final stage
of an “atopic march” from skin or intestinal inflammation
leading to sensitization to aeroallergens, and progressing* Correspondence: Antoine.Magnan@univ-nantes.fr
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unless otherwise stated.to bronchial asthma [4-6]. Although some of the risk
factors of atopic asthma are well known [7], the precise
interplay of events involving gut, skin and pulmonary
inflammation is not completely understood. It has been
suggested that a previous food allergy could increase
Th2 inflammation and amplify the asthmatic phenotype
in humans, which would give evidence for a link be-
tween food allergy and allergic asthma [8,9].
Ovalbumin (OVA) is a frequent food allergen in egg-
induced anaphylaxis and atopic dermatitis (AD) in child-
hood. House dust mites (HDM) [10] are also strongly
involved in AD, in which skin disruption facilitates al-
lergen penetration, allergic sensitization and eczema
[11,12]. Overall HDM is recognized as the main aller-
gen for atopic asthma [1]. OVA and HDM are therefore
highly relevant to the atopic march, inducing food allergy,
skin sensitization, and asthma. OVA- or HDM-based al-
lergic models induce eosinophil- and/or neutrophil-basedl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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adjuvants and doses of allergens used [13-15]. Yet, none of
these models completely explains the atopic march, from
intestinal or skin sensitization to asthma.
In the present study, we establish a model of Dermato-
phagoides farinae (Der f )-induced asthma with primary
OVA-induced food allergy. The choice of these allergens
was driven by their relevance in clinics, with OVA being
a major food allergen in early childhood, involved in AD,
and Der f a major allergen of HDM, largely involved in
AD, allergic rhinitis and asthma in late childhood and
adults (1, 10). We demonstrate that food sensitization
to one allergen primes the immune system to build an
amplified pulmonary inflammation associated with an
exaggerated immune reaction in response to another,
unrelated allergen.
Methods
Induction of food, respiratory, and combined food/
respiratory allergy
6 weeks old female Balb/c mice were sensitized for the
food allergy, respiratory allergy or both. The inductionFigure 1 Mouse model of type I mediated food allergy to Ovalbumin
with PBS (CTRL) OVA/Al(OH)3 (OVA) every 7 days and subsequently challen
Analyses were done on day 32, three days after the last challenge. At the e
measure (B) total IgE, OVA-specific IgE, (C) total IgG1 and IgG2a by ELISA in
represented as mean ± SEM (n =5 mice/group). *p < 0.05, **p < 0.01.of the food allergy was carried out on days 0, 14 and
21 by intraperitoneal (i.p.) injection of 10 μg of OVA
(Sigma-Aldrich, L'Isle d'Abeau Chesnes, France) diluted
in 100 μl of Imject® Alum (Pierce, Rockford, USA) fol-
lowed by intra-gastric (i.g.) administration of 20 mg of
OVA solubilized in water on D27 to D29 (Figure 1A).
Control mice were i.p.-sensitized with alum and chal-
lenged with water. Respiratory allergy was obtained as
follows: mice were sensitized on days 0, 7, 14 and 21 by
cutaneous application (p.c.) of 500 μg of total extract of
Der f (Stallergenes, Antony, France) diluted in 20 μL of
dimethylsulfoxyde (DMSO, Sigma-Aldrich, L'Isle d'Abeau
Chesnes, France). Mice were challenged intranasally (i.n.)
with 250 μg of Der f on D27 and D34 (Figure 2A) diluted
in PBS. Control mice were sensitized with DMSO alone
and challenged with PBS. Combined food and respira-
tory allergy was obtained by applying the two protocols
successively (Figure 3A). For respiratory sensitization
and challenges animals were anesthetized with 100 μl
of i.p. xylazine (15 mg/kg) and 100 μl of i.m. ketamine
(80 mg/kg). Mice were sacrificed using dolethal (Veto-
quinol). Analyses were performed three days after the. (A) Balb/c mice were sensitized three times intra-peritoneally (i.p.)
ged with two doses of PBS or 20 mg OVA by intra-gastric (i.g) gavage.
nd of experiment, blood was removed and serum collected to
control (white circles) and OVA-allergic mice (black squares). Data are
Figure 2 Mouse model of Der f-induced asthma defined by hyperresponsiveness and pulmonary infiltrate. (A) Balb/c mice sensitized to
Der f by percutaneous (p.c) application on days 0, 7, 14 and 21 and then challenged intranasally (i.n) with Der f on day 27 and 34. Mice were
sacrificed after one or three days after the first (day 28 and 30) or second challenge (day 35 and 37). On day 35, blood was removed and serum
collected to measure (B) total IgE, Der f-specific IgE, by ELISA in control (white circles) and Der f-allergic mice (black squares). (C) Measurement of
airway hyperresponsiveness (AHR) after one and three days after the first (day 27) and second challenge (day 34) in control (CTRL, white circle
dotted line) and in allergic (Der f, black square plain line) mice. AHR is displayed by Penh/Penh0 (pause enhanced ratio to basal pause enhanced).
(D) Airway resistances to increasing doses of methacholin on day 37 in CTRL and Der-f sensitized mice. (E) Inflammatory score in lungs one and
three days after the first (day 27) and second challenge (day 34) in CTRL and Der f mice. (F) Representative hematoxylin-eosin staining of a lung
section in control (CTRL) and allergic mice (Der f) on day 35. Scale bars represent 100 μm. Data are represented as mean ± SEM (n = at least 5
mice/group). *p < 0.05, **p < 0.01, ***p < 0.001.
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lenge (day 28 and 30) and after the 2nd respiratory chal-
lenge (day 35 and 37).
Gastro-intestinal tract monitoring
After 2 hours fast, fecal pellets were collected, counted
and weighed. For permeability measurements, the jeju-
num and proximal colon were removed, washed in cold
Krebs’s solution and sections were mounted in Ussing
chambers (Physiological instruments, San Diego, CA).
Paracellular permeability was assayed by fluorescein–5.6
sulfonic acid (1 mg/mL, Invitrogen) gradient over time
by fluorimetry (Varioskan, Thermo SA, France). Trans-
cellular permeability was assayed by HRP (10 mg/ml,
Sigma-Aldrich) activity over the time using a Varioskan
spectrofluorimeter (Thermo SA, Saint Herblain, France).
Airway hyperresponsiveness measurement
Unrestrained mice were nebulized in a plethysmog-
raphy chamber with increasing doses of methacholin
(0-40 mg/mL). Airway function was measured and ex-
pressed as enhanced pause (Penh) (Emka, Paris, France).Dynamic lung resistances were measured using the flexi-
vent® (SCIREQ, Emka) system. Mice were anesthetized
with a mix of xylazine (0.05 mg/kg), ventilated, paralyzed
with rocuronium bromide (Organon, 10 mg/ml) and neb-
ulized with methacholin (0-20 mg/mL). Airway resistances
were continuously monitored and recorded according to
manufacturer’s instructions.
Histology
1 mL of paraformaldehyde (PFA) 4% was administered
intra-tracheally. Excised lungs were fixed in PFA 4%, em-
bedded in paraffin, cut and stained with hematoxylin
and eosin for morphological study and inflammation scor-
ing from 0 to 7 representing bronchial epithelial cell dys-
trophy grades from 0 to 3 and peribronchial/perivascular
inflammatory infiltrate abundance grades from 0 to 4.
Immunoglobulin assays
Total IgE and IgG1 were assayed by ELISA in serum.
Specific anti-Der f 1 IgE and anti-OVA IgE were as-
sessed by indirect ELISA. 96 wells plates were coated
with sodium bicarbonate 50 μM and 0.25 μg of purified
Figure 3 Influence of exacerbation on lung and BAL inflammation in Der f-induced asthma model. (A) Eosinophil, neutrophil and
lymphocyte counts in BAL and lungs one day after the first (day 28) and second challenge (day 35) in control (white bars) and asthmatic (black bars)
mice. (B) Measurement of airway hyperresponsiveness (AHR) and airway resistances to increasing doses of methacholin in CTRL (white circles),
sensitized (black circles), challenged (white diamonds) and asthmatic mice on day 28. (C) Total cells, lymphocytes, eosinophil and neutrophil
counts in lungs one day after the first challenge (day 28) in CTRL (white bars), percutaneously sensitized (p.c, light grey), intra-nasally challenged
(i.n, dark grey) and asthmatic (Der f, black) mice. (D) Measurement of IL-5, IL-10, IFN-γ and IL-17 secretion in BAL cells on day 28 and 35 in CTRL
and Der f mice by ELISA. Data are represented as mean ± SEM (n = at least 5 mice/group). *p < 0.05, **p < 0.01, ***p < 0.001.
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OVA (Sigma-Aldrich, L'Isle d'Abeau Chesnes, France)
and left overnight at 4°C. Wells were then incubated
with bovine serum albumine 1% for 12 h at 4°C, washed,
filled with sera diluted in CGS1 (Cosmo Bio, California,
USA) and incubated overnight at 4°C. Specific Ig was re-
vealed with anti-mouse IgE (AbD serotec, Colmar, France)
coupled to HRP. Substrate ABTS (Roche, Boulogne-
Billancourt, France) was added and absorbance measured
at 405 nm with VictorTMX3 (PerkinElmer, Courtaboeuf,
France).
Flow cytometry in broncho-alveolar lavages and lungs
Broncho-alveolar lavage (BAL) fluid was recovered by
intra-tracheal administration and aspiration of 1 mL of
PBS. To obtain total lung immune cells, the lungs were
disrupted and digested at 37°C for 1H in a solution con-
taining Dnase I (Roche) and collagenase II (Invitrogen).
To determine the immune profile, lung and BAL cells
were counted and stained by flow cytometry as previously
described [16] with specific anti-mouse antibodies: CD3-
APC, CD8-APC-H7, CD19 PE-Cy7, F4/80-FITC, Ly6G-
PerCP-Cy5.5, and CCR3-PE (R&D, Lille, France). Analyses
were performed on a BD LSR™ II with BD FACSDiva™
software (BD Biosciences).Cytokine quantification in broncho-alveolar lavage
Cytokines (IL-4, IL-5, IL-10, IFN-γ, IL-17, chemoattract-
ant keratinocyte (KC) and CCL5/RANTES (Regulation
on Activation, Normal T cell Expressed and Secreted)
were quantified by Luminex (BioPlex 200 system, Bio-Rad,
Marnes-La-Coquette, France) according to manufacturer’s
instructions (Bio-Rad).
Statistics
GraphPad Prism 4.0b (Graphpad Software Inc., La Jolla,
CA USA) was used. Data are expressed as mean ± standard
error to the mean (SEM). Means were compared among
groups using ANOVA. In case of positive ANOVA means
were compared by Mann-Whitney test. Results were cor-
rected by a Bonferroni multiple comparisons correction
test. A p < 0.05 was considered statistically significant.
Results
OVA i.p. sensitization and oral challenge induce type I
food allergy and increase gut permeability
To characterize the food allergy part of the model, serum-
allergen specificity and intestinal function of OVA and
control mice were evaluated on day 32, 3 days after final
challenge (Figure 1A). Type I allergy was confirmed by
a significant increase of total (697 vs 5603 ng/ml) and
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in OVA mice compared to controls (Figure 1B). Th2-
supported IgG1, and Th1-supported IgG2a proteoglycan-
specific antibody levels in serum were determined. The
IgG2a predominance (1.33.107 vs 1,399.106 ng/ml) in al-
lergic mice suggests a bias towards a Th2-type response
(Figure 1C). Intestinal parameters were assessed 30 mi-
nutes after the final intra-gastric challenge (day 29)
(Table 1). Transit time, fresh faecal pellet weight and
humidity were similar in both groups. Contrastingly, a
significant increase in paracellular permeability was
found in OVA mice, whereas there was no difference
is transcellular permeability between the groups. OVA
sensitization did not trigger any change in respiratory
function or airway inflammation (not shown). Taken
together these results show that OVA i.p. sensitization
and intra-gastric challenge induces a systemic type I
allergy and an increase in intestinal permeability.
Der f skin sensitization and intranasal challenge induce
type 1 respiratory allergy with increased airways
resistances and lung inflammation
In order to follow as closely as possible the atopic march,
asthma was induced by percutaneous sensitization and in-
tranasal challenge (Figure 2A). Total and specific serum
IgE levels significantly increased in Der f-allergic mice on
day 35, one day after the 2nd challenge (0.36 vs 1.14 μg/ml
and 0.44 vs 1.6 A.U respectively) (Figure 2B), but not on
day 26, before challenges (not shown), suggesting that skin
exposure is not sufficient for inducing a full allergic re-
sponse and that bronchial exposure is essential. Regarding
respiratory function, Der f-allergic mice displayed airway
hyperresponsiveness (AHR) one and three days (day 28
and day 30) after the first challenge (Figure 2C). A second
challenge on day 35 increased AHR dramatically, a result
confirmed using flexivent® on day 37 (Figure 2D). OverallTable 1 OVA-induced food allergy model induces minor
alterations on intestinal parameters
CTRL OVA
Total transit time (mn) 185,10 ± 39,84 188,25 ± 54,31
Total fresh fecal pellet weight (mg) 145,67 ± 45,41 129,90 ± 56,73
% humidity of fecal pellet 73,65 ± 2,62 73,32 ± 3,25
Paracellular in vivo permeability
(Fluo (AU)/μl plasma)
6,12 ± 1,60 7,73 ± 2,88*
Transcellular in vivo permeability
(ng/ml)
403,60 ± 150,89 503,05 ± 268,98
Paracellular ex-vivo permeability in
jejunum (sulfonic acid flux (slope))
0,60 ± 0,34 1,43 ± 0,15*
Paracellular ex-vivo permeability in
colon (sulfonic acid flux (slope))
0,23 ± 0,04 0,18 ± 0,02
Intestinal parameters including transit time, pellet weight and humidity and
permeability were measured 30 minutes after the last challenge with OVA on
day 29 in control (CTRL) and in OVA-induced food allergy (OVA) mice. *p<0.05.tissue inflammation was assessed by histological evalu-
ation of lung sections at the same time points. A clear in-
crease in inflammation between the 1st (day 28) and the
2nd challenge (day 35) (Figure 2E) was observed, concor-
dant with respiratory function measurements. Figure 2F
shows the extensive perivascular and peribronchial cell in-
filtration on day 35 (Figure 2F).
In order to characterize the inflammatory profile in-
duced by Der f in the model, the proportions of eosino-
phils, neutrophils and lymphocytes in lungs and BAL were
analyzed after the 1st (day 28) and the 2nd challenge (day
35) (Figure 3). On day 28, a significant increase in neutro-
phils (16.103 versus 130.103 cells), but not in eosinophils
and lymphocytes was identified in BAL (Figure 3A). These
results were confirmed in lungs, with a significant increase
of total cell concentration, due to a major influx of neutro-
phils (287.103 vs 1275.103 cells) and to a lesser extent of
eosinophils and lymphocytes (Figure 3A). After the second
challenge (day 35) proportions of eosinophils, neutrophils
and lymphocytes were strongly elevated in BAL and lungs
from allergic mice compared to control mice and mice
which had only undergone one challenge (Figure 3A).
In order to assess the role of skin sensitization in the
asthma process, experiments were also performed in chal-
lenged, unsensitized mice and in sensitized, unchallenged
mice. In neither group difference in AHR was found com-
pared to control mice (Figure 3B). In addition, sensitiza-
tion or challenge alone did not induce inflammation,
detected by cell infiltration in the lungs (Figure 3C). These
results show that skin sensitization to HDM is necessary,
but not sufficient, to induce asthma. In order to further
define the mechanisms of allergen-induced inflamma-
tion, cytokines specific to Th1 (IFN-γ), Th2 (IL-5), Th17
(IL-17) and Treg (IL-10) activation were assayed in BAL.
IFN-γ, IL-17 and IL-10 significantly increased in BAL after
the 1st challenge, whereas IL-5 significantly increased only
after the 2nd (Figure 3D). Interestingly, secretion of IL-5,
IL-10 and IL-17 increased greatly after the 2nd challenge
(Day 35). Similar results were observed in lungs (data not
shown). These data highlight a Th1/Th17-oriented inflam-
mation after the first challenge and a mixed Th2/Th17 in-
flammation after the second challenge.
Overall, these results show that cutaneous sensitization
with Der f followed by Der f respiratory challenges induces
a systemic type one allergy to Der f. Skin sensitization
primes the immune system to respond to a pulmonary
challenge with a biphasic lung inflammation and hugely
increased AHR after a second challenge.
Prior OVA-induced food allergy affects immunoglobulin
levels, respiratory function and inflammation in Der
p-induced asthma.
In order to assess whether a synergy between OVA and
HDM allergies could aggravate asthma in food allergic
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respiratory allergy, food allergy and dual (food plus re-
spiratory) allergy. Immunoglobulin levels were assayed
in serum obtained 3 days after the last intranasal HDM
challenge. Total IgG1 and IgE (Figure 4B) levels were
significantly higher in dual allergy mice compared to
control and mice with asthma only. However total IgG1
levels were not higher in dual allergy mice than in mice
allergic to OVA only. As expected, OVA-specific IgE
levels were significantly higher in food allergic mice. In
dual allergy mice, no further increase in OVA-specific
IgE was observed (Figure 4C, upper panel).
In contrast, Der f-specific IgE levels were higher in
asthmatic mice and significantly higher in dual allergy
mice compared to control and mice allergic to OVA only
(Figure 4C, lower panel). Dual allergy mice displayed sig-
nificantly greater AHR than mice sensitized to one aller-
gen only (Figure 4D). Inflammation was also increased
in BAL and lungs of mice with two allergies (Figure 5A
and B, respectively). Neutrophils, eosinophils and lympho-
cytes numbers were elevated in dual allergy mice com-
pared to all other groups, with a predominant eosinophil
infiltrate. Cytokine production was analysed in BAL su-
pernatants (Figure 5C). As expected from the inflamma-
tory profile, BAL IL-4 and IL-5 levels were increased inFigure 4 OVA-induced gastrointestinal food allergy increases immuno
f-induced asthma model. (A) An OVA food allergy followed by respirator
blood was removed and serum collected to quantify (B) total IgG1 and IgE
(CTRL, white circles), OVA-induced food allergy (FA, white squares), Der f-in
with OVA-induced food allergy (FA + RA, black circles) mice. (D) Measurem
the higher dose (lower panel) in control (white circles), FA (white squares),
represented as mean ± SEM (n = at least 5 mice/group). *p < 0.05, **p < 0.0asthmatic mice compared to controls and mice allergic to
OVA only. BAL IL-4 and IL-5 were also found increased
in dual allergy mice compared to asthmatic, OVA allergic
and controls mice. In addition RANTES, a chemotactic
agent for T cells, eosinophils and basophils, was signifi-
cantly higher in dual allergy mice than in others groups.
However, KC, a chemotactic agent for neutrophils, was
found at significantly higher levels in asthmatic mice,
whether they were also OVA-allergic or not, than in con-
trols and mice only allergic to OVA. Similarly, IL-17 was
significantly increased in dual allergy mice compared to
controls, but not compared to mice allergic to a single
agent. IL-10 was found at the same level in all groups
(Figure 5C).
These results show that an OVA food allergy primes
the immune system to increase its response to Der f re-
spiratory challenges in mice percutaneously sensitized to
Der f.
Discussion
In this study, we describe a dual allergy mouse model
with an OVA-induced food allergy followed by asthma
obtained by sensitization to Der f extract. The OVA al-
lergy was induced with 3 intra-peritoneal sensitizations
and 2 intra-gastric challenges. Sensitization was effective,globulin production and allergic airways response in Der
y allergy were induced in Balb/c mice. At the end of the protocol,
as well as (C) Der f-specific and OVA-specific IgE by ELISA in controls
duced asthma (RA, black squares) and bi-allergic Der f-induced asthma
ent of AHR with increasing doses of methacholin (upper panel) and to
RA (black squares) and bi-allergic FA + RA (black circles) mice. Data are
1, ***p < 0.001.
Figure 5 OVA-induced gastrointestinal food allergy influences pulmonary inflammation and cytokine production in Der f-induced
asthma model. Eosinophils, neutrophils and lymphocytes count in (A) BAL and in (B) lungs in control (white bars), FA (light grey bars), RA
(dark grey squares) and bi-allergic FA + RA (black bars) mice. (C) Measurement of IL-4, IL-5, IL-10, IL-17, KC and RANTES secretion in BAL cells by
ELISA in the different groups as in A. Data are represented as mean ± SEM (n = at least 5 mice/group). *p < 0.05, **p < 0.01, ***p < 0.001.
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IgE. Yet, mice displayed no symptom of food allergy, al-
though in-vivo and ex-vivo permeability was increased.
These results contrast with those obtained by Zhang et al.,
[17], who reported severe diarrhea in allergy induced by
i.p. injection of 20 μg and intra-gastric challenges of
100 μg of OVA. Similarly, Perrier et al., [18] observed de-
creased body temperature, pruritus and diarrhea in re-
sponse to intra-gastric sensitizations and challenges with
OVA. These discrepancies could be explained by the fact
that we did not use any adjuvant such as cholera toxin
[18] or Alum [17] during challenges. The sensitization to
OVA was, however, sufficient to facilitate the development
of a subsequent systemic and respiratory response to skin
and lung Der f exposure. It is noteworthy that a similar
scenario occurs in human subjects in whom sensitization
to eggs (presence of specific IgE, positive skin tests) is fre-
quent in atopic subjects who can however eat eggs with-
out any symptoms.
In order to induce the respiratory allergy, mice were
sensitized to HDM through application of Der f extract
on the ear, mimicking HDM sensitization reported in
atopic infants [11]. Repeated skin applications of Der f
would induce eczema [19] but they were limited so that
no lesion occurred. This also reflects the frequent asymp-
tomatic sensitization to HDM seen in atopic subjects. Theeffectiveness of cutaneous sensitization was shown by the
1st challenge, which induced inflammation and AHR in
sensitized mice only. HDM challenges induced, in turn, an
increased bronchial response to methacholin with an in-
crease in inflammation together with a rise in total and
Der f-specific IgE. In addition, lung histology showed pe-
rivascular and peribronchial infiltrates. This pattern of
pulmonary inflammation is highly relevant to the human
situation and was confirmed by a sequential influx of neu-
trophils and eosinophils in the lungs, thus reinforcing the
relevance of the model, in particular for severe human
cases [20] in which a mixed inflammation with a consis-
tent neutrophil infiltrate accompanying the eosinophilic
contingent is frequently found.
Asthma was more pronounced in mice previously sen-
sitized to food with total and specific IgE levels being
higher in these mice compared to all other groups. Most
significantly, AHR was clearly higher in bi-allergic com-
pared to mono-allergic mice. This asthma outcome oc-
curred in a context of increased inflammation in lungs
and BAL. Moreover the presence of a food allergy induced
further BAL IL-4 and IL-5 increase in HDM-sensitized
mice demonstrating a Th2 response enhancement. Ac-
cordingly eosinophil numbers and RANTES production
were dramatically higher in bi-allergic mice compared to
their mono-allergic counterparts [21].
Figure 6 Hypothesis of the influence of food allergy on the development of asthma. Initial sensitization to food allergen will lead to
allergic reaction after allergen re-exposure and induce an increase of intestinal permeability. Then, the development of asthma is influenced by
the previous food allergy and this influence is characterized by an increase of RANTES/CCL5 production (1) as well as a stronger activation and
recruitment of Th2 cells and eosinophils (2). These events will result in an increase of total and Der f-specific IgE (3) to induce activation and
degranulation of inflammatory cells, leading to the induction of a strong bronchial hyperresponsiveness (AHR) and to severe asthma (4).
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intestinal allergy to OVA increases AHR, hypereosinophi-
lia and global hypercellularity in response to subsequent
HDM challenges. However this result was obtained after
three challenges and a fourth challenge was necessary
to induce specific IgG1 production. In addition no
significant pulmonary inflammation was obtained in
non-OVA-sensitized animals. In our study, the initial
trans-cutaneous sensitization explains why we obtained
a significant asthmatic reaction in ovalbumin-naïve
mice and a dramatically enhanced pulmonary inflamma-
tion in response to HDM after only 2 challenges in OVA-
sensitized animals. Our model therefore clearly highlights
the importance of the three allergen-impacted compart-
ments, gut, skin and lungs, and the synergy between
their respective immune responses in the development
of asthma (Figure 6).
Our results demonstrate that a primary sensitization
to one allergen primes the immune system to develop
an intense response to a subsequently administered
fully dissimilar inhaled allergen. This sequence shows
that, rather than being independent events occurring in
response to multiple exposures on a common genetic
background, the sensitization to multiple allergens ob-
served in atopic subjects may result from a synergic
interaction between the immune responses initiated by
each allergen. These results are concordant with epi-
demiological data demonstrating that sensitization to
food, and notably to eggs, is an important risk factorfor sensitization to inhaled allergens, atopic dermatitis
and asthma [23].Conclusion
In conclusion our findings provide a model that could
be instrumental for further elucidating the mechanisms
of atopic march. It will be useful to find new prophylac-
tic strategies to prevent asthma in children with food al-
lergies and/or atopic dermatitis and to test new drugs in
preclinical settings. The full mechanisms involved have
still to be deciphered.
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